Anika Therapeutics, Inc.
DE ˙ DB ˙ US0352551081
11,90 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:AKP / Anika Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership578 shares
Latest Disclosed Value $ 8,381
Citigroup Inc reports 96.44% decrease in ownership of AKP / Anika Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 578 shares of Anika Therapeutics, Inc. (DE:AKP) valued at $6,994 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,218 shares of Anika Therapeutics, Inc.. This represents a change in shares of -96.44% during the quarter. The current value of the position is $6,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ANIKA THERAPEUTICS COM 035255108 578 -15,640 -96.44 8 -94.84 0.0000
2026-02-13 2025-12-31 13F ANIKA THERAPEUTICS COM 035255108 16,218 16,043 9,167.43 156 15,400.00 0.0001
2025-11-10 2025-09-30 13F ANIKA THERAPEUTICS COM 035255108 175 -4,025 -95.83 2 -97.73 0.0000
2025-08-11 2025-06-30 13F ANIKA THERAPEUTICS COM 035255108 4,200 -4,859 -53.64 44 -67.65 0.0000
2025-05-12 2025-03-31 13F ANIKA THERAPEUTICS COM 035255108 9,059 -1,169 -11.43 136 -19.05 0.0001
2025-02-12 2024-12-31 13F ANIKA THERAPEUTICS COM 035255108 10,228 -1,295 -11.24 168 -40.85 0.0001
2024-11-12 2024-09-30 13F ANIKA THERAPEUTICS COM 035255108 11,523 8,168 243.46 285 238.10 0.0002
2024-08-12 2024-06-30 13F ANIKA THERAPEUTICS COM 035255108 3,355 504 17.68 85 16.67 0.0001
2024-05-10 2024-03-31 13F ANIKA THERAPEUTICS COM 035255108 2,851 724 34.04 72 50.00 0.0000
2024-02-09 2023-12-31 13F ANIKA THERAPEUTICS COM 035255108 2,127 2,036 2,237.36 48 4,700.00 0.0000
2023-12-06 2023-09-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 91 -19,925 -99.55 2 -99.81 0.0000
2023-11-09 2023-09-30 13F ANIKA THERAPEUTICS COM 035255108 91 -19,925 2 0.0000
2023-08-10 2023-06-30 13F ANIKA THERAPEUTICS COM 035255108 20,016 -11,465 -36.42 520 -42.48 0.0003
2023-05-11 2023-03-31 13F ANIKA THERAPEUTICS COM 035255108 31,481 8,885 39.32 904 35.33 0.0006
2023-02-09 2022-12-31 13F ANIKA THERAPEUTICS COM 035255108 22,596 -11,784 -34.28 669 -18.34 0.0005
2022-11-10 2022-09-30 13F ANIKA THERAPEUTICS COM 035255108 34,380 9,442 37.86 818 46.86 0.0006
2022-08-10 2022-06-30 13F ANIKA THERAPEUTICS COM 035255108 24,938 3,559 16.65 557 3.72 0.0004
2022-05-12 2022-03-31 13F ANIKA THERAPEUTICS COM 035255108 21,379 -11,653 -35.28 537 -54.61 0.0003
2022-02-10 2021-12-31 13F ANIKA THERAPEUTICS COM 035255108 33,032 12,356 59.76 1,183 34.43 0.0006
2021-11-10 2021-09-30 13F ANIKA THERAPEUTICS COM 035255108 20,676 -25,402 -55.13 880 -55.89 0.0005
2021-08-10 2021-06-30 13F ANIKA THERAPEUTICS COM 035255108 46,078 4,330 10.37 1,995 17.15 0.0012
2021-05-13 2021-03-31 13F ANIKA THERAPEUTICS COM 035255108 41,748 32,316 342.62 1,703 298.83 0.0011
2021-02-11 2020-12-31 13F ANIKA THERAPEUTICS COM 035255108 9,432 2,542 36.89 427 75.00 0.0003
2020-11-12 2020-09-30 13F ANIKA THERAPEUTICS COM 035255108 6,890 -12,050 -63.62 244 -65.87 0.0002
2020-08-12 2020-06-30 13F ANIKA THERAPEUTICS COM 035255108 18,940 1,207 6.81 715 39.38 0.0006
2020-05-12 2020-03-31 13F ANIKA THERAPEUTICS COM 035255108 17,733 -173 -0.97 513 -44.78 0.0005
2020-02-12 2019-12-31 13F ANIKA THERAPEUTICS COM 035255108 17,906 -25,277 -58.53 929 -60.80 0.0007
2019-11-08 2019-09-30 13F ANIKA THERAPEUTICS COM 035255108 43,183 8,893 25.93 2,370 70.14 0.0019
2019-08-12 2019-06-30 13F ANIKA THERAPEUTICS COM 035255108 34,290 26,324 330.45 1,393 478.01 0.0011
2019-05-13 2019-03-31 13F ANIKA THERAPEUTICS COM 035255108 7,966 -1,982 -19.92 241 -28.06 0.0002
2019-02-12 2018-12-31 13F ANIKA THERAPEUTICS COM 035255108 9,948 -90 -0.90 335 -20.99 0.0003
2018-11-13 2018-09-30 13F ANIKA THERAPEUTICS COM 035255108 10,038 6,283 167.32 424 253.33 0.0004
2018-08-10 2018-06-30 13F ANIKA THERAPEUTICS COM 035255108 3,755 -1,160 -23.60 120 -51.02 0.0001
2018-05-11 2018-03-31 13F ANIKA THERAPEUTICS COM 035255108 4,915 -850 -14.74 245 -21.22 0.0002
2018-02-12 2017-12-31 13F ANIKA THERAPEUTICS COM 035255108 5,765 -2,728 -32.12 311 -36.92 0.0002
2017-11-13 2017-09-30 13F ANIKA THERAPEUTICS COM 035255108 8,493 -10,462 -55.19 493 -47.27 0.0004
2017-08-11 2017-06-30 13F ANIKA THERAPEUTICS COM 035255108 18,955 -771 -3.91 935 9.23 0.0008
2017-05-12 2017-03-31 13F ANIKA THERAPEUTICS COM 035255108 19,726 -12,641 -39.06 856 -45.96 0.0008
2017-02-10 2016-12-31 13F ANIKA THERAPEUTICS COM 035255108 32,367 22,101 215.28 1,584 222.61 0.0014
2016-11-10 2016-09-30 13F ANIKA THERAPEUTICS COM 035255108 10,266 1,993 24.09 491 10.59 0.0005
2016-08-12 2016-06-30 13F ANIKA THERAPEUTICS COM 035255108 8,273 -2,464 -22.95 444 -7.50 0.0005
2016-05-13 2016-03-31 13F ANIKA THERAPEUTICS COM 035255108 10,737 9,266 629.91 480 757.14 0.0005
2016-02-12 2015-12-31 13F ANIKA THERAPEUTICS COM 035255108 1,471 -288 -16.37 56 0.00 0.0001
2015-11-13 2015-09-30 13F ANIKA THERAPEUTICS COM 035255108 1,759 -841 -32.35 56 -34.88 0.0001
2015-08-13 2015-06-30 13F ANIKA THERAPEUTICS COM 035255108 2,600 -124 -4.55 86 -23.21 0.0001
2015-05-14 2015-03-31 13F ANIKA THERAPEUTICS COM 035255108 2,724 598 28.13 112 28.74 0.0001
2015-02-17 2014-12-31 13F ANIKA THERAPEUTICS COM 035255108 2,126 -3,311 -60.90 87 -56.28 0.0001
2014-11-14 2014-09-30 13F ANIKA THERAPEUTICS COM 035255108 5,437 1,188 27.96 199 1.02 0.0002
2014-08-14 2014-06-30 13F ANIKA THERAPEUTICS COM 035255108 4,249 279 7.03 197 20.86 0.0002
2014-05-15 2014-03-31 13F ANIKA THERAPEUTICS COM 035255108 3,970 -3,727 -48.42 163 -44.56 0.0002
2014-02-14 2013-12-31 13F ANIKA THERAPEUTICS COM 035255108 7,697 2,864 59.26 294 153.45 0.0003
2013-11-14 2013-09-30 13F ANIKA THERAPEUTICS COM 035255108 4,833 -1,264 -20.73 116 11.54 0.0001
2013-08-14 2013-06-30 13F ANIKA THERAPEUTICS COM 035255108 6,097 6,097 104 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.